ACENXION BIOSYSTEMS INC

Kansas City, KS · Medtech · Private

Automated phenotypic antibiotic susceptibility testing (AST) platform for Neisseria gonorrhoeae using microfluidic cassettes and broth microdilution

acenxionbiosystems.com →
Grants
$5.9M
4 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
3
0 granted · 3 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase II · An automated, scalable, and rapid AST system for Gonorrhea STIs$967,087
Federal grantDepartment of Health and Human Services · Phase II · An automated, scalable, and rapid AST system for Gonorrhea STIs$2,934,394
Federal grantDepartment of Health and Human Services · Phase II · An automated, scalable, and rapid AST system for Gonorrhea STIs$967,307
Federal grantDepartment of Health and Human Services · Phase II · An automated, scalable, and rapid AST system for Gonorrhea STIs$1,000,000
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2083VIGILANT LABORATORIES LLC——
2084AMCYT, INC.——
2085YEARONE LLC——
2086ACENXION BIOSYSTEMS INC——
2087ACOUSTIC MEDSYSTEMS, INC.——
2088ALTYX SURGICAL, INC.——
2089REDWOOD NEURO INC.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 0 granted of 3
  • System And Method For Rapid Susceptibility Testingapplication
  • System And Method For Rapid Susceptibility Testingapplication
  • System And Method For Rapid Susceptibility Testingapplication

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.